Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

ANI Pharmaceuticals Company Profile (NASDAQ:ANIP)

Consensus Ratings for ANI Pharmaceuticals (NASDAQ:ANIP) (?)
Ratings Breakdown: 1 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $39.53 (26.79% upside)

Analysts' Ratings History for ANI Pharmaceuticals (NASDAQ:ANIP)
Show:
DateFirmActionRatingPrice TargetDetailsShare
7/8/2014ZacksDowngradeOutperform -> Neutral$40.60ViewTweet This Rating  Share This Rating on StockTwits
5/21/2014ZacksUpgradeNeutral -> Outperform$35.20ViewTweet This Rating  Share This Rating on StockTwits
5/6/2014Roth CapitalBoost Price Target$36.00 -> $38.00ViewTweet This Rating  Share This Rating on StockTwits
4/22/2014ZacksDowngradeOutperform -> Neutral$31.60ViewTweet This Rating  Share This Rating on StockTwits
3/11/2014ZacksUpgradeNeutral -> Outperform$38.50ViewTweet This Rating  Share This Rating on StockTwits
3/6/2014OppenheimerBoost Price TargetOutperform$31.00 -> $40.00ViewTweet This Rating  Share This Rating on StockTwits
2/20/2014Roth CapitalBoost Price Target$27.00 -> $33.00ViewTweet This Rating  Share This Rating on StockTwits
2/19/2014OppenheimerBoost Price TargetOutperform$29.00 -> $31.00ViewTweet This Rating  Share This Rating on StockTwits
1/24/2014ZacksDowngradeNeutral$23.90ViewTweet This Rating  Share This Rating on StockTwits
1/22/2014OppenheimerInitiated CoverageOutperform$29.00ViewTweet This Rating  Share This Rating on StockTwits
1/7/2014Roth CapitalInitiated CoverageBuy$27.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/25/2012 forward)